The approval came days before the FDA’s expected deadline and makes this the only PD-1 inhibitor approved for resectable ...

The start of AIDS Awareness Month puts a spotlight on how treatment for HIV and AIDS has progressed over the past 40 years.

Panelists discuss how immunotherapies like durvalumab and atezolizumab have emerged as promising treatments for ...

The CHEST Annual Meeting 2024 will take place in Boston, Massachusetts, from October 6 to 9, where experts will discuss ...

Researchers investigate the expression of PARP1 in leukemias with BCR::ABL1 p190+ translocation, finding differential ...

Parth Rali, MD, Temple University Hospital, is looking forward to approaching pulmonary vascular diseases as a spectrum, ...

Hemolysis, elevated liver enzymes, low platelet (HELLP) syndrome, and severe preeclampsia significantly elevate ...

Inpatient hospital care was primarily controlled by 1 or 2 health systems in nearly half of the metropolitan areas in the US ...

B-cell activating factor receptor (BAFF-R) chimeric antigen receptor (CAR) T-cell therapy incited cytotoxic effects on both ...

This interview accompanies the final podcast in our National Recovery Month series with Lyndra Bills, MD, senior medical ...

Surbhi Sidana, MD, MBBS, shares how the addition of an anti-CD38 antibody to the VRd regimen significantly improves ...

A retrospective analysis on newborn screening for spinal muscular atrophy (SMA) provides further evidence for the benefits of ...